Facebook Twitter LinkedIn Google Plus RSS

Aerie Pharmaceuticals files IPO registration

By ,

Bedminster-based Aerie Pharmaceuticals Inc. announced Monday it has registered with the Securities and Exchange Commission for an initial public offering. The offering will consist of common stock.

According to the announcement, the number of shares to be offered and the price range for the offering have not been determined. RBC Capital Markets and Stifel will serve as joint book-running managers for the offering. Lazard Capital Markets and Canaccord Genuity will serve as co-managers.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Related Stories

• Aerie Pharmaceuticals closes IPO• Aerie prices IPO at $67.2M• Burlington Stores Inc. closes $260M IPO• Christie signs incentives overhaul, calling it key to competing with other states for jobs• Three of N.J. biggest health systems announce alliance with Pa. hospitals as Obamacare deadlines near• Challenge triathlon coming to Atlantic City in June• Sources: Christie will sign incentives overhaul this afternoon• Helping execs make sense of social media policies, new Facebook law• Cancer Genetics expands partnership with Roche affiliate• The latest buzz from commercial printer's green initiatives: rooftop beehives• Schindler Elevator wins Hudson Yards contract• Eagle Creek raises $100M in growth capital• Elmer Bancorp declares dividend• Scivantage acquires Portfolio Director from Scottrade• BUSINESS: Obama: 'Locked up' Washington could hurt economy• U.S.: Motive probed for Washington Navy Yard shooter; had mental problems• WORLD: Russia says U.N. report on Syria attack biased• OUT OF THE ORDINARY: Selfless act paying off for Boston homeless man• Panasonic welcomes Christie in officially opening Newark office tower• Latest sale for Rockwood: Chemical company raises $1.1B in unloading specialty businesses• Sports betting advocate: Court ruling against wagers is disappointing, but not a surprise• Jersey City mayor vows to come after developers violating city's tax abatement program• Panel will outline opportunities from changes to crowdfunding laws• Barnabas expands sports physical screenings to each of its hospitals• DiaVacs Inc. appoints chief medical officer• Honeywell completes Intermec acquisition

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy